327 related articles for article (PubMed ID: 22417404)
1. Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional study.
Oyella J; Meya D; Bajunirwe F; Kamya MR
J Int AIDS Soc; 2012 Mar; 15(1):15. PubMed ID: 22417404
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients.
Micol R; Lortholary O; Sar B; Laureillard D; Ngeth C; Dousset JP; Chanroeun H; Ferradini L; Guerin PJ; Dromer F; Fontanet A
J Acquir Immune Defic Syndr; 2007 Aug; 45(5):555-9. PubMed ID: 17577124
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Cryptococcal Antigenemia and associated factors among HIV/AIDS patients on second-line antiretroviral therapy at two hospitals in Western Oromia, Ethiopia.
Geda N; Beyene T; Dabsu R; Mengist HM
PLoS One; 2019; 14(12):e0225691. PubMed ID: 31805085
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence and factors associated with cryptococcal antigenemia in HIV-infected patients in Cotonou/Benin].
Ogouyèmi-Hounto A; Zannou DM; Ayihounton G; Ahouada C; Azon-Kouanou A; Acakpo J; Sissinto Savi de Tove Y; Kinde Gazard D
J Mycol Med; 2016 Dec; 26(4):391-397. PubMed ID: 27641486
[TBL] [Abstract][Full Text] [Related]
5. Cryptococcal antigenemia and associated risk factors among ART-naïve and ART-experienced HIV-infected peoples at selected health institutions of Mekelle, Northern Ethiopia.
Hailu K; Niguse S; Hagos K; Abdulkader M
Microbiologyopen; 2019 Jun; 8(6):e00746. PubMed ID: 30277315
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and outcomes of cryptococcal antigenemia in HIV-seropositive patients hospitalized for suspected tuberculosis in Uganda.
Andama AO; den Boon S; Meya D; Cattamanchi A; Worodria W; Davis JL; Walter ND; Yoo SD; Kalema N; Haller B; Huang L;
J Acquir Immune Defic Syndr; 2013 Jun; 63(2):189-94. PubMed ID: 23542636
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of Cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia.
Alemu AS; Kempker RR; Tenna A; Smitson C; Berhe N; Fekade D; Blumberg HM; Aseffa A
PLoS One; 2013; 8(3):e58377. PubMed ID: 23469276
[TBL] [Abstract][Full Text] [Related]
8. Cryptococcal antigen carriage among HIV infected children aged 6 months to 15 years at Laquintinie Hospital in Douala.
Kalla GCM; Mboumnyemb JF; Assob JCN; Ehouzou Mandeng MN; Kamgaing Noubi N; Okomo Assoumou MC; Mbopi-Keou FX; Monebenimp F
PLoS One; 2021; 16(7):e0253781. PubMed ID: 34242263
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program--Vietnam.
Smith RM; Nguyen TA; Ha HT; Thang PH; Thuy C; Lien TX; Bui HT; Le TH; Struminger B; McConnell MS; Fanfair RN; Park BJ; Harris JR
PLoS One; 2013; 8(4):e62213. PubMed ID: 23626792
[TBL] [Abstract][Full Text] [Related]
10. Cryptococcal antigenemia and its predictors among HIV infected patients in resource limited settings: a systematic review.
Derbie A; Mekonnen D; Woldeamanuel Y; Abebe T
BMC Infect Dis; 2020 Jun; 20(1):407. PubMed ID: 32527231
[TBL] [Abstract][Full Text] [Related]
11. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.
Liechty CA; Solberg P; Were W; Ekwaru JP; Ransom RL; Weidle PJ; Downing R; Coutinho A; Mermin J
Trop Med Int Health; 2007 Aug; 12(8):929-35. PubMed ID: 17697087
[TBL] [Abstract][Full Text] [Related]
12. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
[TBL] [Abstract][Full Text] [Related]
13. No association of cryptococcal antigenemia with poor outcomes among antiretroviral therapy-experienced HIV-infected patients in Addis Ababa, Ethiopia.
Smitson CC; Tenna A; Tsegaye M; Alemu AS; Fekade D; Aseffa A; Blumberg HM; Kempker RR
PLoS One; 2014; 9(1):e85698. PubMed ID: 24465651
[TBL] [Abstract][Full Text] [Related]
14. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm
Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK
BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112
[TBL] [Abstract][Full Text] [Related]
15. Asymptomatic cryptococcal antigenemia is associated with mortality among HIV-positive patients in Indonesia.
Ganiem AR; Indrati AR; Wisaksana R; Meijerink H; van der Ven A; Alisjahbana B; van Crevel R
J Int AIDS Soc; 2014; 17(1):18821. PubMed ID: 24476751
[TBL] [Abstract][Full Text] [Related]
16. Response to comment on "prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda (Oyella et al. 2012)".
Oyella J; Meya D; Bajunirwe F; Kamya MR
J Int AIDS Soc; 2012; 15(2):18003. PubMed ID: 22905363
[No Abstract] [Full Text] [Related]
17. Utility of Cryptococcal Antigen Screening and Evolution of Asymptomatic Cryptococcal Antigenemia among HIV-Infected Women Starting Antiretroviral Therapy in Thailand.
Kwan CK; Leelawiwat W; Intalapaporn P; Anekthananon T; Raengsakulrach B; Peters PJ; McNicholl JM; Park BJ; McConnell MS; Weidle PJ
J Int Assoc Provid AIDS Care; 2014; 13(5):434-7. PubMed ID: 24003059
[TBL] [Abstract][Full Text] [Related]
18. High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique.
Deiss R; Loreti CV; Gutierrez AG; Filipe E; Tatia M; Issufo S; Ciglenecki I; Loarec A; Vivaldo H; Barra C; Siufi C; Molfino L; Tamayo Antabak N
PLoS One; 2021; 16(4):e0250195. PubMed ID: 33901215
[TBL] [Abstract][Full Text] [Related]
19. Multicenter Cryptococcal Antigen Screening of HIV-Infected Patients in Iran.
Bandalizadeh Z; Shokohi T; Moosazadeh M; Keikha N; Seyedpor H; Rabie Rudsari M; Babamahmoudi F; Ghasemian R; Mardani M; Javanian M; Soleimanpour S; Sefidgar AA; Shokri M; Gouya MM; Seyedmousavi S
Curr Microbiol; 2020 Aug; 77(8):1667-1672. PubMed ID: 32296917
[TBL] [Abstract][Full Text] [Related]
20. Comment on "cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda (Oyella et al. 2012)".
Joob B; Wiwanitkit V
J Int AIDS Soc; 2012; 15(2):17977. PubMed ID: 22905364
[No Abstract] [Full Text] [Related]
[Next] [New Search]
